Partial gland cryoablation offers long-term success for prostate cancer patients

FHS
March 7, 2025
2:52 am

A five-year study on men that had just the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.

Who Is Luigi Mangione, the ‘Person of Interest’ in the UnitedHealthcare Murder?

Police arrested a 26-year-old man on Monday in the Manhattan killing of UnitedHealthcare’s CEO after they say a Pennsylvania McDonald’s worker alerted authorities to a

December 10, 2024

Buprenorphine, autism diagnoses, and long Covid: the most-read First Opinion essays of 2023

In a year of abortion restrictions, biotech industry upheaval, and revolutionary drug approvals, First Opinion strived to publish the most surprising, provocative, and conversation-starting essays

December 29, 2023

Revive Therapeutics Announces Initiation of Novel Bucillamine Formulation Development – Psychedelic Alpha

TORONTO, Aug. 22, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company

August 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.